Investors

Lophora is funded by BII (Novo Nordisk Foundation), Innovation Fund Denmark, Export and Investment Fund of Denmark (EIFO), family offices and experienced biotech investors such as Don deBethizy (USA) and Tim Haines (UK).

Upon recently coming out of stealth mode at JPM 2024, Lophora is now preparing a capital increase to raise US$ 5-8 M for completion of Phase I for LPH-5 and advance additional pipeline programs.

Annual reports and Expanded business information can be found on the Danish Central Business Register.